Your browser is no longer supported. Please, upgrade your browser.
Lannett Company, Inc.
Index- P/E- EPS (ttm)-4.96 Insider Own6.50% Shs Outstand39.51M Perf Week-4.03%
Market Cap189.81M Forward P/E- EPS next Y-0.05 Insider Trans-1.36% Shs Float32.73M Perf Month-0.88%
Income-195.30M PEG- EPS next Q-0.12 Inst Own87.40% Short Float20.58% Perf Quarter0.22%
Sales510.70M P/S0.37 EPS this Y88.00% Inst Trans-0.56% Short Ratio5.87 Perf Half Y-39.44%
Book/sh3.14 P/B1.44 EPS next Y40.00% ROA-19.40% Target Price5.75 Perf Year-26.94%
Cash/sh1.94 P/C2.33 EPS next 5Y15.00% ROE-91.30% 52W Range4.12 - 10.70 Perf YTD-30.52%
Dividend- P/FCF2.16 EPS past 5Y-17.20% ROI3.30% 52W High-57.66% Beta1.07
Dividend %- Quick Ratio2.60 Sales past 5Y6.10% Gross Margin18.10% 52W Low9.95% ATR0.21
Employees954 Current Ratio3.80 Sales Q/Q-22.20% Oper. Margin-42.70% RSI (14)44.74 Volatility3.42% 4.71%
OptionableYes Debt/Eq4.92 EPS Q/Q57.80% Profit Margin-38.20% Rel Volume0.28 Prev Close4.68
ShortableYes LT Debt/Eq4.92 EarningsMay 05 AMC Payout- Avg Volume1.15M Price4.53
Recom3.00 SMA20-2.84% SMA50-4.09% SMA200-21.69% Volume316,145 Change-3.21%
Mar-20-19Initiated SunTrust Hold
Aug-20-18Downgrade ROTH Capital Buy → Neutral
Aug-20-18Downgrade Raymond James Outperform → Mkt Perform
Jan-24-18Initiated Goldman Neutral
Jun-29-16Initiated Deutsche Bank Hold $26
Mar-24-16Downgrade Canaccord Genuity Buy → Sell $28 → $18
Feb-04-16Upgrade Craig Hallum Hold → Buy
Nov-05-15Downgrade Craig Hallum Buy → Hold
Sep-03-15Reiterated ROTH Capital Buy $61 → $68
Jul-21-15Initiated Susquehanna Positive
Feb-05-15Reiterated ROTH Capital Buy $54 → $61
Nov-24-14Reiterated ROTH Capital Buy $66 → $60
Nov-04-14Reiterated ROTH Capital Buy $53 → $66
Nov-04-14Reiterated Canaccord Genuity Buy $55 → $73
Nov-04-14Downgrade Oppenheimer Outperform → Perform $53
Oct-13-14Reiterated Oppenheimer Outperform $51 → $53
Jul-15-14Reiterated Oppenheimer Outperform $49 → $52
May-06-14Resumed Canaccord Genuity Buy $55
Feb-10-14Reiterated Canaccord Genuity Buy $29 → $55
Feb-07-14Reiterated Oppenheimer Outperform $41 → $45
Aug-04-21 09:34AM  
Jul-29-21 06:52AM  
Jul-12-21 06:52AM  
Jun-09-21 03:25AM  
Jun-01-21 06:52AM  
May-28-21 05:39PM  
May-27-21 05:47PM  
May-06-21 01:01AM  
May-05-21 08:05PM  
Apr-28-21 12:33PM  
Apr-22-21 04:15PM  
Apr-09-21 06:52AM  
Apr-06-21 08:12AM  
Apr-01-21 08:30AM  
Mar-21-21 09:14PM  
Mar-18-21 05:25PM  
Mar-16-21 09:35PM  
Mar-14-21 10:31PM  
Mar-12-21 06:25AM  
Mar-10-21 07:48AM  
Mar-09-21 10:58PM  
Mar-07-21 02:39PM  
Mar-03-21 03:00AM  
Feb-22-21 02:04PM  
Feb-20-21 06:30PM  
Feb-19-21 01:15AM  
Feb-15-21 10:16PM  
Feb-13-21 02:40PM  
Feb-11-21 01:35PM  
Feb-09-21 06:53AM  
Feb-08-21 07:10PM  
Feb-06-21 11:09PM  
Feb-04-21 01:33PM  
Feb-03-21 09:31PM  
Jan-27-21 06:52AM  
Dec-15-20 10:48AM  
Dec-10-20 09:24PM  
Dec-07-20 05:42PM  
Nov-30-20 06:52AM  
Nov-06-20 07:38AM  
Nov-04-20 08:31PM  
Nov-03-20 06:52AM  
Oct-28-20 12:32PM  
Aug-27-20 06:07AM  
Aug-26-20 08:30PM  
Aug-25-20 10:14AM  
Aug-19-20 06:52AM  
Aug-17-20 04:30PM  
Aug-03-20 06:53AM  
Jul-27-20 06:52AM  
Jul-23-20 06:52AM  
Jul-16-20 12:14PM  
Jul-13-20 07:34AM  
Jun-22-20 03:04PM  
Jun-11-20 06:52AM  
May-25-20 10:37AM  
May-08-20 07:28AM  
May-07-20 01:07PM  
May-06-20 08:15PM  
Apr-29-20 06:52AM  
Apr-28-20 08:22AM  
Apr-27-20 12:31PM  
Apr-08-20 06:52AM  
Apr-07-20 12:57PM  
Mar-31-20 06:54AM  
Mar-09-20 06:52AM  
Feb-28-20 10:27AM  
Feb-12-20 12:16AM  
Feb-05-20 06:05PM  
Jan-30-20 06:52AM  
Jan-29-20 12:31PM  
Jan-14-20 01:03PM  
Jan-13-20 11:51AM  
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crew Timothy CChief Executive OfficerJun 14Buy5.0010,00050,000411,058Jun 15 04:29 PM
FARBER JEFFREYDirectorMay 28Buy4.3710,00043,7001,678,510Jun 01 04:44 PM
LEPORE PATRICK GDirectorMay 11Buy4.1820,00083,600260,326May 12 04:50 PM
Taveira PaulDirectorFeb 19Sale6.5830,000197,40060,401Feb 10 04:57 PM
Drabik David ADirectorFeb 08Sale6.0833,445203,34651,513Feb 10 04:51 PM
Crew Timothy CChief Executive OfficerNov 10Buy6.043,00018,120402,963Nov 12 04:01 PM
Rewolinski MelissaDirectorSep 03Sale5.3214,15075,27830,621Jun 10 04:43 PM
Abt JohnChief Quality and OperationsSep 03Sale5.271,0005,27086,015Sep 04 03:24 PM
Crew Timothy CChief Executive OfficerSep 01Buy5.103,00015,300399,232Sep 02 04:18 PM